Thrombospondin-2 and extracellular matrix assembly

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 8, 2014, Pages 2396-2402

  Calabro, Nicole E ^a   Kristofik, Nina J ^a   Kyriakides, Themis R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Collagen; Decellularization; Extracellular matrix; Thrombospondin

Indexed keywords

COLLAGEN; MATRIX METALLOPROTEINASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; THROMBOSPONDIN 2;

ANGIOGENESIS; BLOOD VESSEL FUNCTION; BONE; CELL ADHESION; CELL FUNCTION; CELL INTERACTION; CONNECTIVE TISSUE DISEASE; DISEASE MODEL; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX ASSEMBLY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SCLERODERMA; TISSUE REPAIR; VASCULAR REMODELING;

MUS;

ANGIOGENESIS; COLLAGEN; DECELLULARIZATION; EXTRACELLULAR MATRIX; THROMBOSPONDIN;

ANIMALS; COLLAGEN; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; HUMANS; PHENOTYPE; THROMBOSPONDINS; TISSUE ENGINEERING;

EID: 84903374328     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2014.01.013     Document Type: Review

References (75)

1. C. Frantz, K.M. Stewart, and V.M. Weaver The extracellular matrix at a glance J. Cell Sci. 123 2010 4195 4200
2. J.F. Bateman, R.P. Boot-Handford, and S.R. Lamande Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations Nat. Rev. Genet. 10 2009 173 183
3. P. Bornstein, and E.H. Sage Matricellular proteins: extracellular modulators of cell function Curr. Opin. Cell Biol. 14 2002 608 616
4. G.S. Schultz, and A. Wysocki Interactions between extracellular matrix and growth factors in wound healing Wound Repair Regen. 17 2009 153 162
5. P. Fratzl Collagen: Structure and Mechanics 2008 Springer New York
6. Y. Mao, and J.E. Schwarzbauer Fibronectin fibrillogenesis, a cell-mediated matrix assembly process Matrix Biol. 24 2005 389 399
7. D.J. Leeming, A.C. Bay-Jensen, E. Vassiliadis, M.R. Larsen, K. Henriksen, and M.A. Karsdal Post-translational modifications of the extracellular matrix are key events in cancer progression: opportunities for biochemical marker development Biomarkers 16 2011 193 205
8. J.H. Miner Extracellular Matrix in Development and Disease 2005 Elsevier London
9. J.C. Adams, and J. Lawler The thrombospondins Cold Spring Harb. Perspect. Biol. 3 2011 a009712
10. A. Agah, T.R. Kyriakides, J. Lawler, and P. Bornstein The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice Am. J. Pathol. 161 2002 831 839
11. M.M. Krady, J. Zeng, J. Yu, S. Maclauchlan, E.A. Skokos, W. Tian, P. Bornstein, W.C. Sessa, and T.R. Kyriakides Thrombospondin-2 modulates extracellular matrix remodeling during physiological angiogenesis Am. J. Pathol. 173 2008 879 891
12. T.R. Kyriakides, and S. Maclauchlan The role of thrombospondins in wound healing, ischemia, and the foreign body reaction J. Cell Commun. Signal. 3 2009 215 225
13. J.E. Murphy-Ullrich, and R.V. Iozzo Thrombospondins in physiology and disease: new tricks for old dogs Matrix Biol. 31 2012 152 154
14. P.R. Lawler, and J. Lawler Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2 Cold Spring Harbor perspectives in medicine 2 2012 a006627
15. T.R. Kyriakides, Y.H. Zhu, L.T. Smith, S.D. Bain, Z. Yang, M.T. Lin, K.G. Danielson, R.V. Iozzo, M. LaMarca, C.E. McKinney, E.I. Ginns, and P. Bornstein Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis J. Cell Biol. 140 1998 419 430
16. T.R. Kyriakides, J.W. Tam, and P. Bornstein Accelerated wound healing in mice with a disruption of the thrombospondin 2 gene J. Invest. Dermatol. 113 1999 782 787
17. T.R. Kyriakides, K.J. Leach, A.S. Hoffman, B.D. Ratner, and P. Bornstein Mice that lack the angiogenesis inhibitor, thrombospondin 2, mount an altered foreign body reaction characterized by increased vascularity Proc. Natl. Acad. Sci. U. S. A. 96 1999 4449 4454
18. Z. Yang, T.R. Kyriakides, and P. Bornstein Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2 Mol. Biol. Cell 11 2000 3353 3364
19. Z. Yang, D.K. Strickland, and P. Bornstein Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2 J. Biol. Chem. 276 2001 8403 8408
20. A. Agah, T.R. Kyriakides, and P. Bornstein Proteolysis of cell-surface tissue transglutaminase by matrix metalloproteinase-2 contributes to the adhesive defect and matrix abnormalities in thrombospondin-2-null fibroblasts and mice Am. J. Pathol. 167 2005 81 88
21. S. Maclauchlan, E.A. Skokos, A. Agah, J. Zeng, W. Tian, J.M. Davidson, P. Bornstein, and T.R. Kyriakides Enhanced angiogenesis and reduced contraction in thrombospondin-2-null wounds is associated with increased levels of matrix metalloproteinases-2 and -9, and soluble VEGF J. Histochem. Cytochem. 57 2009 301 313
22. C.M. Overall, and C. Lopez-Otin Strategies for MMP inhibition in cancer: innovations for the post-trial era Nat. Rev. 2 2002 657 672
23. S. Lee, S.M. Jilani, G.V. Nikolova, D. Carpizo, and M.L. Iruela-Arispe Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors J. Cell Biol. 169 2005 681 691
24. K.D. Hankenson, and P. Bornstein The secreted protein thrombospondin 2 is an autocrine inhibitor of marrow stromal cell proliferation J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 17 2002 415 425
25. D. Burke, M. Dishowitz, M. Sweetwyne, E. Miedel, K.D. Hankenson, and D.J. Kelly The role of oxygen as a regulator of stem cell fate during fracture repair in TSP2-null mice J. Orthop. Res. Off. Publ. Orthop. Res. Soc. 31 2013 1585 1596
26. M. Hirao, N. Tamai, N. Tsumaki, H. Yoshikawa, and A. Myoui Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification J. Biol. Chem. 281 2006 31079 31092
27. K.D. Hankenson, S.D. Bain, T.R. Kyriakides, E.A. Smith, S.A. Goldstein, and P. Bornstein Increased marrow-derived osteoprogenitor cells and endosteal bone formation in mice lacking thrombospondin 2 J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 15 2000 851 862
28. K.D. Hankenson, B.J. Ausk, S.D. Bain, P. Bornstein, T.S. Gross, and S. Srinivasan Mice lacking thrombospondin 2 show an atypical pattern of endocortical and periosteal bone formation in response to mechanical loading Bone 38 2006 310 316
29. K.D. Hankenson, I.E. James, S. Apone, G.B. Stroup, S.M. Blake, X. Liang, M.W. Lark, and P. Bornstein Increased osteoblastogenesis and decreased bone resorption protect against ovariectomy-induced bone loss in thrombospondin-2- null mice Matrix Biol. 24 2005 362 370
30. D.K. Taylor, J.A. Meganck, S. Terkhorn, R. Rajani, A. Naik, R.J. O'Keefe, S.A. Goldstein, and K.D. Hankenson Thrombospondin-2 influences the proportion of cartilage and bone during fracture healing J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 24 2009 1043 1054
31. E. Miedel, M.I. Dishowitz, M.H. Myers, D. Dopkin, Y.Y. Yu, T.S. Miclau, R. Marcucio, J. Ahn, and K.D. Hankenson Disruption of thrombospondin-2 accelerates ischemic fracture healing J. Orthop. Res. Off. Publ. Orthop. Res. Soc. 31 2013 935 943
32. H.S. Shitaye, S.P. Terkhorn, J.A. Combs, and K.D. Hankenson Thrombospondin-2 is an endogenous adipocyte inhibitor Matrix Biol. 29 2010 549 556
33. A.I. Alford, S.P. Terkhorn, A.B. Reddy, and K.D. Hankenson Thrombospondin-2 regulates matrix mineralization in MC3T3-E1 pre-osteoblasts Bone 46 2010 464 471
34. A.I. Alford, A.Z. Golicz, A.L. Cathey, and A.B. Reddy Thrombospondin-2 facilitates assembly of a type-I collagen-rich matrix in marrow stromal cells undergoing osteoblastic differentiation Connect. Tissue Res. 54 2013 275 282
35. S. MacLauchlan, J. Yu, M. Parrish, T.A. Asoulin, M. Schleicher, M.M. Krady, J. Zeng, P.L. Huang, W.C. Sessa, and T.R. Kyriakides Endothelial nitric oxide synthase controls the expression of the angiogenesis inhibitor thrombospondin 2 Proc. Natl. Acad. Sci. U. S. A. 108 2011 E1137 E1145
36. Y. Tang, E.A. Scheef, S. Wang, C.M. Sorenson, C.B. Marcus, C.R. Jefcoate, and N. Sheibani CYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expression Blood 113 2009 744 754
37. T.L. Poulos Cytochrome P450: molecular architecture, mechanism, and prospects for rational inhibitor design Pharm. Res. 5 1988 67 75
38. S. Fichtlscherer, S. Dimmeler, S. Breuer, R. Busse, A.M. Zeiher, and I. Fleming Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease Circulation 109 2004 178 183
39. T. Hillig, P. Krustrup, I. Fleming, T. Osada, B. Saltin, and Y. Hellsten Cytochrome P450 2C9 plays an important role in the regulation of exercise-induced skeletal muscle blood flow and oxygen uptake in humans J. Physiol. 546 2003 307 314
40. N. Lopes, D. Gregg, S. Vasudevan, H. Hassanain, P. Goldschmidt-Clermont, and H. Kovacic Thrombospondin 2 regulates cell proliferation induced by Rac1 redox-dependent signaling Mol. Cell. Biol. 23 2003 5401 5408
41. T.R. Kyriakides, Y.H. Zhu, Z. Yang, and P. Bornstein The distribution of the matricellular protein thrombospondin 2 in tissues of embryonic and adult mice J. Histochem. Cytochem. 46 1998 1007 1015
42. P. Bornstein, T.R. Kyriakides, Z. Yang, L.C. Armstrong, and D.E. Birk Thrombospondin 2 modulates collagen fibrillogenesis and angiogenesis J. Investig. Dermatol. Symp. Proc. 5 2000 61 66
43. H.F. Bigg, A.D. Rowan, M.D. Barker, and T.E. Cawston Activity of matrix metalloproteinase-9 against native collagen types I and III FEBS J. 274 2007 1246 1255
44. B. Schroen, S. Heymans, U. Sharma, W.M. Blankesteijn, S. Pokharel, J.P. Cleutjens, J.G. Porter, C.T. Evelo, R. Duisters, R.E. van Leeuwen, B.J. Janssen, J.J. Debets, J.F. Smits, M.J. Daemen, H.J. Crijns, P. Bornstein, and Y.M. Pinto Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy Circ. Res. 95 2004 515 522
45. G.C. van Almen, M. Swinnen, P. Carai, W. Verhesen, J.P. Cleutjens, J. D'Hooge, F.K. Verheyen, Y.M. Pinto, B. Schroen, P. Carmeliet, and S. Heymans Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy J. Mol. Cell. Cardiol. 51 2011 318 328
46. M. Swinnen, D. Vanhoutte, G.C. Van Almen, N. Hamdani, M.W. Schellings, J. D'Hooge, J. Van der Velden, M.S. Weaver, E.H. Sage, P. Bornstein, F.K. Verheyen, T. VandenDriessche, M.K. Chuah, D. Westermann, W.J. Paulus, F. Van de Werf, B. Schroen, P. Carmeliet, Y.M. Pinto, and S. Heymans Absence of thrombospondin-2 causes age-related dilated cardiomyopathy Circulation 120 2009 1585 1597
47. A. Agah, T.R. Kyriakides, N. Letrondo, B. Bjorkblom, and P. Bornstein Thrombospondin 2 levels are increased in aged mice: consequences for cutaneous wound healing and angiogenesis Matrix Biol. 22 2004 539 547
48. N.G. Frangogiannis Matricellular proteins in cardiac adaptation and disease Physiol. Rev. 92 2012 635 688
49. I. Kajihara, M. Jinnin, K. Yamane, T. Makino, N. Honda, T. Igata, S. Masuguchi, S. Fukushima, Y. Okamoto, M. Hasegawa, M. Fujimoto, and H. Ihn Increased accumulation of extracellular thrombospondin-2 due to low degradation activity stimulates type I collagen expression in scleroderma fibroblasts Am. J. Pathol. 180 2012 703 714
50. L. Schaefer, and R.V. Iozzo Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction J. Biol. Chem. 283 2008 21305 21309
51. S. Goldoni, A. Humphries, A. Nystrom, S. Sattar, R.T. Owens, D.J. McQuillan, K. Ireton, and R.V. Iozzo Decorin is a novel antagonistic ligand of the Met receptor J. Cell Biol. 185 2009 743 754
52. K.G. Danielson, H. Baribault, D.F. Holmes, H. Graham, K.E. Kadler, and R.V. Iozzo Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility J. Cell Biol. 136 1997 729 743
53. S. Chakravarti, T. Magnuson, J.H. Lass, K.J. Jepsen, C. LaMantia, and H. Carroll Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican J. Cell Biol. 141 1998 1277 1286
54. L. Svensson, A. Aszodi, F.P. Reinholt, R. Fassler, D. Heinegard, and A. Oldberg Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon J. Biol. Chem. 274 1999 9636 9647
55. Y. Ezura, S. Chakravarti, A. Oldberg, I. Chervoneva, and D.E. Birk Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons J. Cell Biol. 151 2000 779 788
56. K. Andrikopoulos, X. Liu, D.R. Keene, R. Jaenisch, and F. Ramirez Targeted mutation in the col5a2 gene reveals a regulatory role for type V collagen during matrix assembly Nat. Genet. 9 1995 31 36
57. L.A. Parapia, and C. Jackson Ehlers-Danlos syndrome - a historical review Br. J. Haematol. 141 2008 32 35
58. J. Wu, A. Utani, H. Endo, and H. Shinkai Deficiency of the decorin core protein in the variant form of Ehlers-Danlos syndrome with chronic skin ulcer J. Dermatol. Sci. 27 2001 95 103
59. K.S. Christopherson, E.M. Ullian, C.C. Stokes, C.E. Mullowney, J.W. Hell, A. Agah, J. Lawler, D.F. Mosher, P. Bornstein, and B.A. Barres Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis Cell 120 2005 421 433
60. T.R. Kyriakides, P. Rojnuckarin, M.A. Reidy, K.D. Hankenson, T. Papayannopoulou, K. Kaushansky, and P. Bornstein Megakaryocytes require thrombospondin-2 for normal platelet formation and function Blood 101 2003 3915 3923
61. H. Reinecke, T.E. Robey, J.L. Mignone, V. Muskheli, P. Bornstein, and C.E. Murry Lack of thrombospondin-2 reduces fibrosis and increases vascularity around cardiac cell grafts Cardiovasc. Pathol. Off. J. Soc. Cardiovasc. Pathol. 22 2013 91 95
62. B. Lange-Asschenfeldt, W. Weninger, P. Velasco, T.R. Kyriakides, U.H. von Andrian, P. Bornstein, and M. Detmar Increased and prolonged inflammation and angiogenesis in delayed-type hypersensitivity reactions elicited in the skin of thrombospondin-2-deficient mice Blood 99 2002 538 545
63. Y.W. Park, Y.M. Kang, J. Butterfield, M. Detmar, J.J. Goronzy, and C.M. Weyand Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis Am. J. Pathol. 165 2004 2087 2098
64. D. Gospodarowicz, D. Delgado, and I. Vlodavsky Permissive effect of the extracellular matrix on cell proliferation in vitro Proc. Natl. Acad. Sci. U. S. A. 77 1980 4094 4098
65. Q.P. Pham, F.K. Kasper, L. Scott Baggett, R.M. Raphael, J.A. Jansen, and A.G. Mikos The influence of an in vitro generated bone-like extracellular matrix on osteoblastic gene expression of marrow stromal cells Biomaterials 29 2008 2729 2739
66. S.F. Badylak, D. Taylor, and K. Uygun Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds Annu. Rev. Biomed. Eng. 13 2011 27 53
67. D.O. Freytes, R.S. Tullius, J.E. Valentin, A.M. Stewart-Akers, and S.F. Badylak Hydrated versus lyophilized forms of porcine extracellular matrix derived from the urinary bladder J. Biomed. Mater. Res. A 87 2008 862 872
68. R.V. Iozzo Proteoglycans: Structure, Biology, and Molecular Interactions 2000 Marcel Dekker New York
69. D.O. Freytes, J. Martin, S.S. Velankar, A.S. Lee, and S.F. Badylak Preparation and rheological characterization of a gel form of the porcine urinary bladder matrix Biomaterials 29 2008 1630 1637
70. S.B. Seif-Naraghi, M.A. Salvatore, P.J. Schup-Magoffin, D.P. Hu, and K.L. Christman Design and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineering Tissue Eng. Part A 16 2010 2017 2027
71. S.B. Seif-Naraghi, D. Horn, P.J. Schup-Magoffin, and K.L. Christman Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor Acta Biomater. 8 2012 3695 3703
72. P. Rompre, F.A. Auger, L. Germain, V. Bouvard, C.A. Lopez Valle, J. Thibault, and A. Le Duy Influence of initial collagen and cellular concentrations on the final surface area of dermal and skin equivalents: a Box-Behnken analysis In Vitro Cell. Dev. Biol. J. Tissue Cult. Assoc. 26 1990 983 990
73. F. Grinnell Fibroblast biology in three-dimensional collagen matrices Trends Cell Biol. 13 2003 264 269
74. C. Helary, I. Bataille, A. Abed, C. Illoul, A. Anglo, L. Louedec, D. Letourneur, A. Meddahi-Pelle, and M.M. Giraud-Guille Concentrated collagen hydrogels as dermal substitutes Biomaterials 31 2010 481 490
75. S.B. Seif-Naraghi, J.M. Singelyn, M.A. Salvatore, K.G. Osborn, J.J. Wang, U. Sampat, O.L. Kwan, G.M. Strachan, J. Wong, P.J. Schup-Magoffin, R.L. Braden, K. Bartels, J.A. DeQuach, M. Preul, A.M. Kinsey, A.N. DeMaria, N. Dib, and K.L. Christman Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction Sci. Transl. Med. 5 2013 173ra125